Invention Application
US20170008971A1 METHODS OF TREATING HER2-POSITIVE CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-HER2 ANTIBODIES
审中-公开
使用PD-1轴结合拮抗剂和抗HER2抗体治疗HER2阳性癌症的方法
- Patent Title: METHODS OF TREATING HER2-POSITIVE CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-HER2 ANTIBODIES
- Patent Title (中): 使用PD-1轴结合拮抗剂和抗HER2抗体治疗HER2阳性癌症的方法
-
Application No.: US15184966Application Date: 2016-06-16
-
Publication No.: US20170008971A1Publication Date: 2017-01-12
- Inventor: Mark S. DENNIS , Allen EBENS , Bryan IRVING , Teemu T. JUNTTILA , Ji LI
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Main IPC: C07K16/32
- IPC: C07K16/32 ; A61K39/395 ; A61K45/06 ; C07K16/28 ; C07K16/30
Abstract:
The invention provides compositions and methods for treating HER2-postitive cancers. The method comprising administering a PD-1 axis binding antagonist and an antibody that targets HER2.
Information query
